FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer

FDA expands approval of Zelboraf (vemurafenib) to include treatment of certain adult patients with Erdheim-Chester Disease, a rare blood cancer. This is the first FDA-approved treatment for ECD.
Source: Food and Drug Administration - Category: American Health Source Type: news